BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16680034)

  • 61. [Familial combined hyperlipidemia. II. Risk of ischemic heart disease].
    Vaverková H; Weinbergová O; Horcicka V; Kubasta M; Vrublovský P
    Vnitr Lek; 1986 Sep; 32(9):887-93. PubMed ID: 3765426
    [No Abstract]   [Full Text] [Related]  

  • 62. Familial combined hyperlipidaemia: under - defined and under - diagnosed?
    Wierzbicki AS; Graham CA; Young IS; Nicholls DP
    Curr Vasc Pharmacol; 2008 Jan; 6(1):13-22. PubMed ID: 18220935
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Study of genetic variants of familial hyperlipidaemia in some xanthoma patients.
    Gajra B; Talukder G; Panja SK
    Indian J Dermatol; 1981 Jul; 26(3):1-3. PubMed ID: 7348242
    [No Abstract]   [Full Text] [Related]  

  • 64. Genetic basis of atherosclerosis: part I: new genes and pathways.
    Lusis AJ; Fogelman AM; Fonarow GC
    Circulation; 2004 Sep; 110(13):1868-73. PubMed ID: 15451808
    [No Abstract]   [Full Text] [Related]  

  • 65. Familial combined hyperlipidemia and insulin resistance.
    Frohlich J; Sniderman A
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2100-1. PubMed ID: 11742892
    [No Abstract]   [Full Text] [Related]  

  • 66. Familial combined hyperlipidemia and insulin resistance : distant relatives linked by intra-abdominal fat?
    Eckel RH
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):469-70. PubMed ID: 11304458
    [No Abstract]   [Full Text] [Related]  

  • 67. How should FCHL be defined and how should we think about its metabolic bases?
    Sniderman AD; Ribalta J; Castro Cabezas M
    Nutr Metab Cardiovasc Dis; 2001 Aug; 11(4):259-73. PubMed ID: 11831111
    [No Abstract]   [Full Text] [Related]  

  • 68. Screening for coronary heart disease risk factors.
    Aylett M; Gray D
    J R Coll Gen Pract; 1988 Jun; 38(311):274-5. PubMed ID: 3255817
    [No Abstract]   [Full Text] [Related]  

  • 69. Familial combined hyperlipoproteinemia: experts panel position on diagnostic criteria for clinical practice. Committee of experts of the Atherosclerosis and Dysmetabolic Disorders Study Group.
    Gaddi A; Galetti C; Pauciullo P; Arca M
    Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):304-11. PubMed ID: 10765523
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Familial combined hyperlipidemia and otosclerosis--the occurrence in a large kindred.
    Levy Y; da Silva M; Eliachar I; Glick-Avraham Z; Viskoper RJ; Brook JG
    Am J Med Sci; 1985 Mar; 289(3):107-9. PubMed ID: 3976713
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemia.
    Horra A; Salazar J; Ferré R; Vallvé JC; Guardiola M; Rosales R; Masana L; Ribalta J
    Atherosclerosis; 2009 Oct; 206(2):343-5. PubMed ID: 19339011
    [No Abstract]   [Full Text] [Related]  

  • 72. New technologies for delineating and characterizing the lipid exome: prospects for understanding familial combined hyperlipidemia.
    Horswell SD; Ringham HE; Shoulders CC
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S370-5. PubMed ID: 19023136
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Familial combined hyperlipidemia].
    Rubiés-Prat J; Pedro-Botet J
    Med Clin (Barc); 1997 Jun; 109(5):175-6. PubMed ID: 9289540
    [No Abstract]   [Full Text] [Related]  

  • 74. Familial combined hyperlipidaemia: 1973-1991.
    Castro Cabezas M; de Bruin TW; Erkelens DW
    Neth J Med; 1992 Feb; 40(1-2):83-95. PubMed ID: 1579191
    [No Abstract]   [Full Text] [Related]  

  • 75. Nutrition and genetic susceptibility to common diseases.
    Motulsky AG
    Am J Clin Nutr; 1992 Jun; 55(6 Suppl):1244S-1245S. PubMed ID: 1590264
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Familial combined hyperlipidemia].
    Inoue I
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():309-20. PubMed ID: 17824049
    [No Abstract]   [Full Text] [Related]  

  • 77. A common variant in 11q23.3 associated with hyperlipidemia is mediated by the binding and regulation of GATA4.
    Chou WC; Chen WT; Shen CY
    NPJ Genom Med; 2022 Jan; 7(1):4. PubMed ID: 35046404
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Familial combined hyperlipidemia].
    Sasaki J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():55-9. PubMed ID: 11347130
    [No Abstract]   [Full Text] [Related]  

  • 79. Familial combined hyperlipoproteinemia.
    Spence JD
    CMAJ; 1992 Feb; 146(4):436, 438. PubMed ID: 1737299
    [No Abstract]   [Full Text] [Related]  

  • 80. [Familial combined hyperlipidemia].
    Mabuchi H; Nohara A; Nozue T; Koizumi J; Uno Y
    Nihon Naika Gakkai Zasshi; 2001 Aug; 90(8):1538-43. PubMed ID: 11573278
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.